FDA Inspection 1192276 — Octapharma S.A.S.
The FDA completed an inspection of Octapharma S.A.S. on Dec 6, 2022 in Lingolsheim. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 6, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lingolsheim (France)